To explore whether apoB is superior to LDL-C in assessing residual risk of coronary atherosclerotic heart disease in the Chinese population with statin treatment, and to further investigate whether the concentrations of apoB and LDL-C are associated with the severity of coronary atherosclerosis in participants with statin treatment, we conducted a retrospective cohort study. Here, APOB is linked to coronary atherosclerosis.